Kichul Shin

Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with biological disease-modifying anti-rheumatic drugs (COAST-V): 16 week results of a phase 3 randomised, double-blind, active-controlled and placebo-controlled trial

Désirée van der Heijde, James Cheng‐Chung Wei, Maxime Dougados et al. · The Lancet · 2018 · 349 citations · Full text

Inflammation, Rheumatology, Rheumatoid Disorder +14

Mast cells are an essential hematopoietic component for polyp development

Elias Gounaris, Susan E. Erdman, Clifford R. Restaino et al. · Proceedings of the National Academy of Sciences · 2007 · 249 citations · Full text

Interstitial lung disease in patients with polymyositis, dermatomyositis and amyopathic dermatomyositis

Eun Ha Kang, Eunchae Lee, Kichul Shin et al. · Lara D. Veeken · 2005 · 222 citations

Impact of temporary methotrexate discontinuation for 2 weeks on immunogenicity of seasonal influenza vaccination in patients with rheumatoid arthritis: a randomised clinical trial

Jin Kyun Park, Yun Jong Lee, Kichul Shin et al. · Annals of the Rheumatic Diseases · 2018 · 210 citations · Full text

Human umbilical cord blood-stem cells direct macrophage polarization and block inflammasome activation to alleviate rheumatoid arthritis

Tae–Hoon Shin, Hyung-Sik Kim, Tae‐Wook Kang et al. · Cell Death and Disease · 2016 · 165 citations · Full text